APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Albumin (as Excipient)

Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.

Selected research

Market Outlook & Growth Opportunities

Global Albumin (as Excipient) Market Outlook and Growth Opportunities 2026

Report ID 17396156041 January 2026197 pages

Choose your research edition.

Industry ResearchAlbumin (as Excipient) Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Albumin (as Excipient) Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Albumin (as Excipient) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Albumin (as Excipient) Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Albumin (as Excipient) Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.

The industry's leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019.

By region, Asia-Pacific is the largest consumption market of Albumin (as Excipient), with its sales volume at 70.83%.

Read the full market overview

This report provides an overview of the global Albumin (as Excipient) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Albumin (as Excipient) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Albumin (as Excipient) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Albumin (as Excipient) market size, projected growth trends, production technologies, key applications, and end-use industries.

Albumin (as Excipient) Segment by Company

CSL

Grifols

Takeda

Octapharma

Hualan Bio

CBPO

Shanghai RAAS

Kedrion

LFB Group

Albumedix

Biotest

Merck

Ventria (InVitria)

HiMedia

Albumin (as Excipient) Segment by Type

Human Serum Albumin

Recombinant Albumin

Albumin (as Excipient) Segment by Application

Cell Culture Media

Medical Supplements

Therapeutics

Albumin (as Excipient) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Albumin (as Excipient) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Albumin (as Excipient) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Albumin (as Excipient) significant trends, drivers, influence factors in global and regions.

6. To analyze Albumin (as Excipient) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Albumin (as Excipient) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Albumin (as Excipient) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Albumin (as Excipient).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Albumin (as Excipient) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Albumin (as Excipient) industry.

Chapter 3: Detailed analysis of Albumin (as Excipient) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Albumin (as Excipient) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Albumin (as Excipient) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Albumin (as Excipient) Industry Trends Table 2. Albumin (as Excipient) Industry Drivers Table 3. Albumin (as Excipient) Industry Opportunities and Challenges Table 4. Albumin (as Excipient) Industry Restraints Table 5. Global Albumin (as Excipient) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Albumin (as Excipient) Revenue Share by Company (2021-2026) Table 7. Global Albumin (as Excipient) Sales Volume by Company (MT) & (2021-2026) Table 8. Global Albumin (as Excipient) Sales Volume Share by Company (2021-2026) Table 9. Global Albumin (as Excipient) Average Price (USD/Kg) of Company (2021-2026) Table 10. Global Albumin (as Excipient) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Albumin (as Excipient) Key Company Manufacturing Base & Headquarters Table 12. Global Albumin (as Excipient) Company, Product Type & Application Table 13. Global Albumin (as Excipient) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Albumin (as Excipient) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Human Serum Albumin Table 18. Significant Companies of Recombinant Albumin Table 19. Global Albumin (as Excipient) Sales Volume by Type 2021 VS 2025 VS 2032 (MT) Table 20. Global Albumin (as Excipient) Sales Volume by Type (2021-2026) & (MT) Table 21. Global Albumin (as Excipient) Sales Volume by Type (2027-2032) & (MT) Table 22. Global Albumin (as Excipient) Sales Volume Share by Type (2021-2026) Table 23. Global Albumin (as Excipient) Sales Volume Share by Type (2027-2032) Table 24. Global Albumin (as Excipient) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Albumin (as Excipient) Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Albumin (as Excipient) Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Albumin (as Excipient) Sales Value Share by Type (2021-2026) Table 28. Global Albumin (as Excipient) Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Cell Culture Media Table 30. Significant Companies of Medical Supplements Table 31. Significant Companies of Therapeutics Table 32. Global Albumin (as Excipient) Sales Volume by Application 2021 VS 2025 VS 2032 (MT) Table 33. Global Albumin (as Excipient) Sales Volume by Application (2021-2026) & (MT) Table 34. Global Albumin (as Excipient) Sales Volume by Application (2027-2032) & (MT) Table 35. Global Albumin (as Excipient) Sales Volume Share by Application (2021-2026) Table 36. Global Albumin (as Excipient) Sales Volume Share by Application (2027-2032) Table 37. Global Albumin (as Excipient) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Albumin (as Excipient) Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Albumin (as Excipient) Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Albumin (as Excipient) Sales Value Share by Application (2021-2026) Table 41. Global Albumin (as Excipient) Sales Value Share by Application (2027-2032) Table 42. Global Albumin (as Excipient) Sales by Region: 2021 VS 2025 VS 2032 (MT) Table 43. Global Albumin (as Excipient) Sales by Region (2021-2026) & (MT) Table 44. Global Albumin (as Excipient) Sales Market Share by Region (2021-2026) Table 45. Global Albumin (as Excipient) Sales by Region (2027-2032) & (MT) Table 46. Global Albumin (as Excipient) Sales Market Share by Region (2027-2032) Table 47. Global Albumin (as Excipient) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Albumin (as Excipient) Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Albumin (as Excipient) Sales Value Share by Region (2021-2026) Table 50. Global Albumin (as Excipient) Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Albumin (as Excipient) Sales Value Share by Region (2027-2032) Table 52. Global Albumin (as Excipient) Market Average Price (USD/Kg) by Region (2021-2026) Table 53. Global Albumin (as Excipient) Market Average Price (USD/Kg) by Region (2027-2032) Table 54. Global Albumin (as Excipient) Sales by Country: 2021 VS 2025 VS 2032 (MT) Table 55. Global Albumin (as Excipient) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Albumin (as Excipient) Sales by Country (2021-2026) & (MT) Table 57. Global Albumin (as Excipient) Sales Market Share by Country (2021-2026) Table 58. Global Albumin (as Excipient) Sales by Country (2027-2032) & (MT) Table 59. Global Albumin (as Excipient) Sales Market Share by Country (2027-2032) Table 60. Global Albumin (as Excipient) Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Albumin (as Excipient) Sales Value Market Share by Country (2021-2026) Table 62. Global Albumin (as Excipient) Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Albumin (as Excipient) Sales Value Market Share by Country (2027-2032) Table 64. CSL Company Information Table 65. CSL Business Overview Table 66. CSL Albumin (as Excipient) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 67. CSL Albumin (as Excipient) Product Portfolio Table 68. CSL Recent Development Table 69. Grifols Company Information Table 70. Grifols Business Overview Table 71. Grifols Albumin (as Excipient) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 72. Grifols Albumin (as Excipient) Product Portfolio Table 73. Grifols Recent Development Table 74. Takeda Company Information Table 75. Takeda Business Overview Table 76. Takeda Albumin (as Excipient) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 77. Takeda Albumin (as Excipient) Product Portfolio Table 78. Takeda Recent Development Table 79. Octapharma Company Information Table 80. Octapharma Business Overview Table 81. Octapharma Albumin (as Excipient) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 82. Octapharma Albumin (as Excipient) Product Portfolio Table 83. Octapharma Recent Development Table 84. Hualan Bio Company Information Table 85. Hualan Bio Business Overview Table 86. Hualan Bio Albumin (as Excipient) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 87. Hualan Bio Albumin (as Excipient) Product Portfolio Table 88. Hualan Bio Recent Development Table 89. CBPO Company Information Table 90. CBPO Business Overview Table 91. CBPO Albumin (as Excipient) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 92. CBPO Albumin (as Excipient) Product Portfolio Table 93. CBPO Recent Development Table 94. Shanghai RAAS Company Information Table 95. Shanghai RAAS Business Overview Table 96. Shanghai RAAS Albumin (as Excipient) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 97. Shanghai RAAS Albumin (as Excipient) Product Portfolio Table 98. Shanghai RAAS Recent Development Table 99. Kedrion Company Information Table 100. Kedrion Business Overview Table 101. Kedrion Albumin (as Excipient) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 102. Kedrion Albumin (as Excipient) Product Portfolio Table 103. Kedrion Recent Development Table 104. LFB Group Company Information Table 105. LFB Group Business Overview Table 106. LFB Group Albumin (as Excipient) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 107. LFB Group Albumin (as Excipient) Product Portfolio Table 108. LFB Group Recent Development Table 109. Albumedix Company Information Table 110. Albumedix Business Overview Table 111. Albumedix Albumin (as Excipient) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 112. Albumedix Albumin (as Excipient) Product Portfolio Table 113. Albumedix Recent Development Table 114. Biotest Company Information Table 115. Biotest Business Overview Table 116. Biotest Albumin (as Excipient) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 117. Biotest Albumin (as Excipient) Product Portfolio Table 118. Biotest Recent Development Table 119. Merck Company Information Table 120. Merck Business Overview Table 121. Merck Albumin (as Excipient) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 122. Merck Albumin (as Excipient) Product Portfolio Table 123. Merck Recent Development Table 124. Ventria (InVitria) Company Information Table 125. Ventria (InVitria) Business Overview Table 126. Ventria (InVitria) Albumin (as Excipient) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 127. Ventria (InVitria) Albumin (as Excipient) Product Portfolio Table 128. Ventria (InVitria) Recent Development Table 129. HiMedia Company Information Table 130. HiMedia Business Overview Table 131. HiMedia Albumin (as Excipient) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 132. HiMedia Albumin (as Excipient) Product Portfolio Table 133. HiMedia Recent Development Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Albumin (as Excipient) Distributors List Table 137. Albumin (as Excipient) Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Albumin (as Excipient) Product Image Figure 2. Global Albumin (as Excipient) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Albumin (as Excipient) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Albumin (as Excipient) Sales (2021-2032) & (MT) Figure 5. Global Albumin (as Excipient) Sales Average Price (USD/Kg) & (2021-2032) Figure 6. Global Albumin (as Excipient) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Human Serum Albumin Image Figure 10. Recombinant Albumin Image Figure 11. Global Albumin (as Excipient) Sales Volume by Type (2021 VS 2025 VS 2032) & (MT) Figure 12. Global Albumin (as Excipient) Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Albumin (as Excipient) Sales Volume Share by Type (2021-2032) Figure 14. Global Albumin (as Excipient) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Albumin (as Excipient) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Albumin (as Excipient) Sales Value Share by Type (2021-2032) Figure 17. Cell Culture Media Image Figure 18. Medical Supplements Image Figure 19. Therapeutics Image Figure 20. Global Albumin (as Excipient) Sales Volume by Application (2021 VS 2025 VS 2032) & (MT) Figure 21. Global Albumin (as Excipient) Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Albumin (as Excipient) Sales Volume Share by Application (2021-2032) Figure 23. Global Albumin (as Excipient) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Albumin (as Excipient) Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Albumin (as Excipient) Sales Value Share by Application (2021-2032) Figure 26. Global Albumin (as Excipient) Sales by Region: 2021 VS 2025 VS 2032 (MT) Figure 27. Global Albumin (as Excipient) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Albumin (as Excipient) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Albumin (as Excipient) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Albumin (as Excipient) Sales Value (2021-2032) & (US$ Million) Figure 31. North America Albumin (as Excipient) Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Albumin (as Excipient) Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Albumin (as Excipient) Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Albumin (as Excipient) Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Albumin (as Excipient) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Albumin (as Excipient) Sales Value (2021-2032) & (US$ Million) Figure 37. South America Albumin (as Excipient) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Albumin (as Excipient) Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Albumin (as Excipient) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Albumin (as Excipient) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Albumin (as Excipient) Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Albumin (as Excipient) Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Human Serum Albumin
  • Recombinant Albumin
Applications
  • Cell Culture Media
  • Medical Supplements
  • Therapeutics
Companies covered
  • CSL
  • Grifols
  • Takeda
  • Octapharma
  • Hualan Bio
  • CBPO
  • Shanghai RAAS
  • Kedrion
  • LFB Group
  • Albumedix
  • Biotest
  • Merck
  • Ventria (InVitria)
  • HiMedia

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Albumin (as Excipient) Sales Value (2021-2032)
  4. 1.2.2 Global Albumin (as Excipient) Sales Volume (2021-2032)
  5. 1.2.3 Global Albumin (as Excipient) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Albumin (as Excipient) Market Dynamics
  1. 2.1 Albumin (as Excipient) Industry Trends
  2. 2.2 Albumin (as Excipient) Industry Drivers
  3. 2.3 Albumin (as Excipient) Industry Opportunities and Challenges
  4. 2.4 Albumin (as Excipient) Industry Restraints
3 Albumin (as Excipient) Market by Company
  1. 3.1 Global Albumin (as Excipient) Company Revenue Ranking in 2025
  2. 3.2 Global Albumin (as Excipient) Revenue by Company (2021-2026)
  3. 3.3 Global Albumin (as Excipient) Sales Volume by Company (2021-2026)
  4. 3.4 Global Albumin (as Excipient) Average Price by Company (2021-2026)
  5. 3.5 Global Albumin (as Excipient) Company Ranking (2024-2026)
  6. 3.6 Global Albumin (as Excipient) Company Manufacturing Base and Headquarters
  7. 3.7 Global Albumin (as Excipient) Company Product Type and Application
  8. 3.8 Global Albumin (as Excipient) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Albumin (as Excipient) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Albumin (as Excipient) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Albumin (as Excipient) Market by Type
  1. 4.1 Albumin (as Excipient) Type Introduction
  2. 4.1.1 Human Serum Albumin
  3. 4.1.2 Recombinant Albumin
  4. 4.2 Global Albumin (as Excipient) Sales Volume by Type
  5. 4.2.1 Global Albumin (as Excipient) Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Albumin (as Excipient) Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Albumin (as Excipient) Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Albumin (as Excipient) Sales Value by Type
  9. 4.3.1 Global Albumin (as Excipient) Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Albumin (as Excipient) Sales Value by Type (2021-2032)
  11. 4.3.3 Global Albumin (as Excipient) Sales Value Share by Type (2021-2032)
5 Albumin (as Excipient) Market by Application
  1. 5.1 Albumin (as Excipient) Application Introduction
  2. 5.1.1 Cell Culture Media
  3. 5.1.2 Medical Supplements
  4. 5.1.3 Therapeutics
  5. 5.2 Global Albumin (as Excipient) Sales Volume by Application
  6. 5.2.1 Global Albumin (as Excipient) Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Albumin (as Excipient) Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Albumin (as Excipient) Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Albumin (as Excipient) Sales Value by Application
  10. 5.3.1 Global Albumin (as Excipient) Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Albumin (as Excipient) Sales Value by Application (2021-2032)
  12. 5.3.3 Global Albumin (as Excipient) Sales Value Share by Application (2021-2032)
6 Albumin (as Excipient) Regional Sales and Value Analysis
  1. 6.1 Global Albumin (as Excipient) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Albumin (as Excipient) Sales by Region (2021-2032)
  3. 6.2.1 Global Albumin (as Excipient) Sales by Region: 2021-2026
  4. 6.2.2 Global Albumin (as Excipient) Sales by Region (2027-2032)
  5. 6.3 Global Albumin (as Excipient) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Albumin (as Excipient) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Albumin (as Excipient) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Albumin (as Excipient) Sales Value by Region (2027-2032)
  9. 6.5 Global Albumin (as Excipient) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Albumin (as Excipient) Sales Value (2021-2032)
  12. 6.6.2 North America Albumin (as Excipient) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Albumin (as Excipient) Sales Value (2021-2032)
  15. 6.7.2 Europe Albumin (as Excipient) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Albumin (as Excipient) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Albumin (as Excipient) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Albumin (as Excipient) Sales Value (2021-2032)
  21. 6.9.2 South America Albumin (as Excipient) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Albumin (as Excipient) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Albumin (as Excipient) Sales Value Share by Country, 2025 VS 2032
7 Albumin (as Excipient) Country-level Sales and Value Analysis
  1. 7.1 Global Albumin (as Excipient) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Albumin (as Excipient) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Albumin (as Excipient) Sales by Country (2021-2032)
  4. 7.3.1 Global Albumin (as Excipient) Sales by Country (2021-2026)
  5. 7.3.2 Global Albumin (as Excipient) Sales by Country (2027-2032)
  6. 7.4 Global Albumin (as Excipient) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Albumin (as Excipient) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Albumin (as Excipient) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Albumin (as Excipient) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Albumin (as Excipient) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Albumin (as Excipient) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CSL
  2. 8.1.1 CSL Company Information
  3. 8.1.2 CSL Business Overview
  4. 8.1.3 CSL Albumin (as Excipient) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 CSL Albumin (as Excipient) Product Portfolio
  6. 8.1.5 CSL Recent Developments
  7. 8.2 Grifols
  8. 8.2.1 Grifols Company Information
  9. 8.2.2 Grifols Business Overview
  10. 8.2.3 Grifols Albumin (as Excipient) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Grifols Albumin (as Excipient) Product Portfolio
  12. 8.2.5 Grifols Recent Developments
  13. 8.3 Takeda
  14. 8.3.1 Takeda Company Information
  15. 8.3.2 Takeda Business Overview
  16. 8.3.3 Takeda Albumin (as Excipient) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Takeda Albumin (as Excipient) Product Portfolio
  18. 8.3.5 Takeda Recent Developments
  19. 8.4 Octapharma
  20. 8.4.1 Octapharma Company Information
  21. 8.4.2 Octapharma Business Overview
  22. 8.4.3 Octapharma Albumin (as Excipient) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Octapharma Albumin (as Excipient) Product Portfolio
  24. 8.4.5 Octapharma Recent Developments
  25. 8.5 Hualan Bio
  26. 8.5.1 Hualan Bio Company Information
  27. 8.5.2 Hualan Bio Business Overview
  28. 8.5.3 Hualan Bio Albumin (as Excipient) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hualan Bio Albumin (as Excipient) Product Portfolio
  30. 8.5.5 Hualan Bio Recent Developments
  31. 8.6 CBPO
  32. 8.6.1 CBPO Company Information
  33. 8.6.2 CBPO Business Overview
  34. 8.6.3 CBPO Albumin (as Excipient) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 CBPO Albumin (as Excipient) Product Portfolio
  36. 8.6.5 CBPO Recent Developments
  37. 8.7 Shanghai RAAS
  38. 8.7.1 Shanghai RAAS Company Information
  39. 8.7.2 Shanghai RAAS Business Overview
  40. 8.7.3 Shanghai RAAS Albumin (as Excipient) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai RAAS Albumin (as Excipient) Product Portfolio
  42. 8.7.5 Shanghai RAAS Recent Developments
  43. 8.8 Kedrion
  44. 8.8.1 Kedrion Company Information
  45. 8.8.2 Kedrion Business Overview
  46. 8.8.3 Kedrion Albumin (as Excipient) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Kedrion Albumin (as Excipient) Product Portfolio
  48. 8.8.5 Kedrion Recent Developments
  49. 8.9 LFB Group
  50. 8.9.1 LFB Group Company Information
  51. 8.9.2 LFB Group Business Overview
  52. 8.9.3 LFB Group Albumin (as Excipient) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 LFB Group Albumin (as Excipient) Product Portfolio
  54. 8.9.5 LFB Group Recent Developments
  55. 8.10 Albumedix
  56. 8.10.1 Albumedix Company Information
  57. 8.10.2 Albumedix Business Overview
  58. 8.10.3 Albumedix Albumin (as Excipient) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Albumedix Albumin (as Excipient) Product Portfolio
  60. 8.10.5 Albumedix Recent Developments
  61. 8.11 Biotest
  62. 8.11.1 Biotest Company Information
  63. 8.11.2 Biotest Business Overview
  64. 8.11.3 Biotest Albumin (as Excipient) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Biotest Albumin (as Excipient) Product Portfolio
  66. 8.11.5 Biotest Recent Developments
  67. 8.12 Merck
  68. 8.12.1 Merck Company Information
  69. 8.12.2 Merck Business Overview
  70. 8.12.3 Merck Albumin (as Excipient) Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Merck Albumin (as Excipient) Product Portfolio
  72. 8.12.5 Merck Recent Developments
  73. 8.13 Ventria (InVitria)
  74. 8.13.1 Ventria (InVitria) Company Information
  75. 8.13.2 Ventria (InVitria) Business Overview
  76. 8.13.3 Ventria (InVitria) Albumin (as Excipient) Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Ventria (InVitria) Albumin (as Excipient) Product Portfolio
  78. 8.13.5 Ventria (InVitria) Recent Developments
  79. 8.14 HiMedia
  80. 8.14.1 HiMedia Company Information
  81. 8.14.2 HiMedia Business Overview
  82. 8.14.3 HiMedia Albumin (as Excipient) Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 HiMedia Albumin (as Excipient) Product Portfolio
  84. 8.14.5 HiMedia Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Albumin (as Excipient) Value Chain Analysis
  2. 9.1.1 Albumin (as Excipient) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Albumin (as Excipient) Sales Mode & Process
  6. 9.2 Albumin (as Excipient) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Albumin (as Excipient) Distributors
  9. 9.2.3 Albumin (as Excipient) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst